08/11/2024  17:35:55 Var. +0.055 Volume Denaro08/11/2024 Lettera17:40:28 Capitalizzazione di mercato Dividend Y. Rapporto P/E
16.880EUR +0.33% 732,941
Fatturato: 12.28 mill.
-Quantità in denaro: - -Quantità in lettera: - 67.21 bill.EUR - -

Descrizione business

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Emma Walmsley
Consiglio di amministrazione
Julie Brown, Diana Conrad, James Ford, Luke Miels, Sally Jackson, Tony Wood, Shobie Ramakrishnan, David Redfern, Regis Simard, Phil Thomson, Deborah Waterhouse
Consiglio di sorveglianza
Jonathan Symonds, Emma Walmsley, Iain Mackay, Elizabeth (Liz) McKee Anderson, Charles Bancroft, Dr. Hal Barron, Dr. Anne Beal, Dr. Harry (Hal) C Dietz, Dr. Jesse Goodman, Urs Rohner, Dr. Vishal Sikka, Wendy Becker, Dr. Jeannie Lee
 

Dati aziendali

Name: GlaxoSmithKline PLC
Indirizzo: 980 Great West Road,UK-Brentford, Middlesex TW8 9GS
Telefono: +44-20-8047-5000
Fax: -
E-mail: -
Internet: www.gsk.com
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 41.74%
Data dell'IPO: -

Rapporti con gli investitori

Name: Nick Stone
IR telefono: +44 7717 618834
IR Fax: -
IR e-mail: GSK.Investor-Relations@gsk.com

Company calendar

CW 46 | 14/11/2024 Ex-Dividend
CW 46 | 15/11/2024 Record Date
CW 2 | 09/01/2025 Dividend Payment
CW 6 | 05/02/2025 Report 4th Quarter
CW 8 | 20/02/2025 Ex-Dividend
 

Principali azionisti

Altri
 
89.27%
BlackRock, Inc
 
5.69%
Dodge & Cox
 
5.04%